National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E

Past Highlights
   
 
Results: 1 -4 of 4         results per page
View Search Criteria | Help With Results
           
Last Modified: 10/2/2007     First Published: 8/10/2007  

1.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase II, Phase I


Biomarker/Laboratory analysis, Treatment


Active


Over 18


NCI


NU07C1
NU 07C1, NCT00516282


2.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase II, Phase I


Treatment


Active


60 and over


Other


0702009008
VNP40101M, NCT00655395

Last Modified: 10/27/2008     First Published: 7/14/2006  

3.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase II


Treatment


Active


60 and over


Pharmaceutical / Industry


VION-CLI-043
NCT00354276, EUDRACT-2006-001853-89


4.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase I


Treatment


Active


18 to 65


Other


2005-0844
NCT00521859

   
   

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov